thatmr , instead of looking at old news, with studies done with bacterial grown DNA, look and read updated news, and read the results done by highly respected doctors, and the results that are amazing . SynDNA is going to change this world . Lots of potential investors were losts by over analyzed past press releases , all you got to understand is that cytogenix is sitting on a paradigm shift in medicine ,cytogenix got the patents ,the scientists, and the syndna world by the horns.
HOUSTON--(BUSINESS WIRE)--June 29, 2006--CytoGenix, Inc. (OTCBB:CYGX) Dr. Yin Chen, CytoGenix Chief Scientific Officer; Ms. Harilyn McMicken, CytoGenix, Laboratory Director; Dr. Cy Stein, Professor of Medicine at Albert Einstein School of Medicine; and Dr. John Rossi, Chairman and Professor in the Division of Molecular Biology, City of Hope have collaborated in a study that has been accepted for publication in the peer-reviewed journal Clinical Cancer Research. Drs. Stein and Rossi are directors of the company and members of its scientific advisory board.
The paper titled "The Function of Bcl-2 Protein in 518A2 Melanoma Cells In Vivo Differs Dramatically from its In Vitro Role" presents data from experiments performed on mice xenografted with human melanoma tumors and demonstrates that Bcl-2 protein could be an important therapeutic target in reducing or regressing tumors.
Dr. Cy Stein, the lead investigator, states, "This study helps to validate the use of the CytoGenix proprietary ssDNA technology in settings where permanent down-regulation of gene expression is needed, leading in this case, to unexpected and dramatic results."
Dr. Yin Chen states, "This is a significant step forward for CytoGenix because it is the first time that the company's ssDNA technology has been shown to be effective an in vivo cancer model
